# Efficacy of Topical Lidocaine to Decrease Discomfort With Intranasal Midazolam Administration

> **NCT02396537** · NA · COMPLETED · sponsor: **University of Alabama at Birmingham** · enrollment: 77 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Lidocaine
- **DRUG:** Midazolam
- **DRUG:** 0.9% Saline

## Key facts

- **NCT ID:** NCT02396537
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 77 (ACTUAL)
- **Last updated:** 2017-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02396537

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02396537, "Efficacy of Topical Lidocaine to Decrease Discomfort With Intranasal Midazolam Administration". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02396537. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*